Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome-Reference-Cited by-同舟云学术

Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome

Published:2018-11-16 Issue: Volume:24 Page:8239-8249
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Jia Lizhou¹,Yang Xiaobing²,Tian Wei³,Guo Siqi²,Huang Wenbin²,Zhao Wei²

Affiliation:

1. Key Laboratory of Antibody Technique of National Health and Family Planning Commission, Nanjing Medical University, Nanjing, Jiangsu, China (mainland)

2. Department of Pathology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China (mainland)

3. Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer;Cancer Letters;2024-04

2. Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer;Technology in Cancer Research & Treatment;2024-01

3. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential;Cancers;2023-12-26

4. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus;Hematological Oncology;2023-06-10

5. MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer;Biology;2023-03-16